Back to Results
First PageMeta Content
Nutrition / Organochlorides / Obesity / Bioethics / Pharmacology / Sibutramine / Placebo / Weight loss / Management of obesity / Medicine / Health / Biology


Microsoft Word - CSR 2.0 Synopsis MLAY[removed]doc
Add to Reading List

Document Date: 2014-12-04 15:09:34

Open Document

File Size: 35,71 KB

Share Result on Facebook

Company

AEs / Abbott Laboratories / /

Event

FDA Phase / /

IndustryTerm

test product / intrauterine device / herbal products / food / /

MedicalCondition

respiratory tract infections / nutritional obesity / Insulin resistance / headaches / tachycardia / diarrhea / constipation / dyslipidemia / rhinitis / /

MedicalTreatment

birth control / hysterectomy / /

Movie

Quality of Life / /

Organization

Institutional Review Board / Study Centre / Independent Ethics Committee / /

Position

investigator / /

Product

Sibutramine (ABT-991) Phase / sibutramine / MLAY-02-001 / Obese Non / /

Technology

2006 Protocol / 47 Per Protocol / 2 Clinical Trial Report SYNOPSIS Protocol / /

SocialTag